Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs

Toxicology

Volumn 144, Issue 1-3, 2000, Pages 205-210

  Kourounakis, Panos N ^a   Tsiakitzis, Karyofyllis ^a   Kourounakis, Angeliki P ^a   Galanakis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cysteamine; Inflammation; NSAID; Oxidative stress; Ulcerogenicity

Indexed keywords

DICLOFENAC; IBUPROFEN; INDOMETACIN; MERCAPTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; TOLFENAMIC ACID;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHEMICAL MODIFICATION; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; MELENA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; STOMACH ULCER;

AMIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CYSTEAMINE; DRUG DESIGN; FEMALE; FREE RADICAL SCAVENGERS; GASTROINTESTINAL DISEASES; RATS; RATS, INBRED F344;

EID: 0034599842     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00208-5     Document Type: Article

References (31)

1. Andreadou I., Rekka E., Demopoulos V.J., Kourounakis P.N. Effect of some novel ethylendiamine and ethanolamine derivatives on carrageenan induced inflammation: correlation with antioxidant activity and structural characteristics. Res. Commun. Chem. Pathol. Pharmacol. 78:1992;245-248.
2. Andreadou I., Rekka E., Demopoulos V.J., Bijioo G., Kourounakis P.N. Synthesis, antioxidant and anti-inflammatory activity of novel substituted alkylenodiamines and ethanolamines. Arzheim.-Forsch. Drug Res. 47:1997;643-647.
3. Aralcon de la Lastra C., Motilva V., Martin L.J., Nieto A., Barranco M.D., Cabeza J., Herrerias J.M. Protective effect of melatonin on indomethacin-induced gastric injury in rats. J. Pineal Res. 26:1999;101-107.
4. Bannwarth B., Netter P., Lapicque F., Pere P., Tomas P., Gaucher A. Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Relationship to analgesic activity. Eur. J. Clin. Pharmacol. 38:1990;343-346.
5. Bragt P.C., Bansberg J.I., Bontu I.L. Anti-inflammatory effects of free radical scavengers and antioxidants. Further support for proinflammatory roles of endogenous hydrogen peroxide and lipid peroxides. Inflammation. 4:1980;289-299.
6. Breitner J.C.S. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Res. Med. 47:1996;401-411.
7. Butterfield D.A. Commentary: Alzheimer's disease: a disorder of oxidative stress. Alzheimer's Dis. Rev. 1:1996;68-70.
8. Cambell N.B., Halushka P.V. Lipid derived autocoids. Eicosanoides and platelet activating factor. Hardman J.G., Limbird A.E., Molinoff P.B., Ruddon R.W., Goodman Gilman A. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 1996;601-616 McGraw-Hill, New York.
9. Del Soldato P., Forschi D., Benonti G., Scarpignato C. Oxygen free radicals interact with indomethacin to cause of gastrointestinal injury. Agents Actions. 17:1986;484-488.
10. Gavalas A., Hadjipetrou L., Kourounakis P. Synthesis of novel derivatives of aroyl-aminoalcohols and 3-amino-substituted 1-phenylpropanols with potential anti-inflammatory and immunomodulating activity. J. Pharm. Pharmacol. 50:1998;583-591.
11. Halliwell B. How to characterise a biological antioxidant. Free Radic. Res. Commun. 9:1990;1-32.
12. Halliwell B., Gutteridge J.M.C. Chronic inflammation and the autoimmune disease. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1989;422-438 Oxford University Press, Oxford.
13. Hassan A., Martin E., Puig-Parellada P. Role of antioxidants in gastric mucosal damage induced by indomethacin in rats. Methods Find. Exp. Clin. Pharmacol. 20:1998;849-854.
14. Insel P.A. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. Hardman J.G., Limbird A.E., Molinoff P.B., Ruddon R.W., Goodman Gilman A. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 1996;617-657 McGraw-Hill, New York.
15. Kalaria R.N., Cohen D.L., Premkumar D.R.D. Cellular aspects of the inflammatory response in Alzheimer's disease. Neurodegeneration. 5:1996;497-503.
16. Konturek P.C., Konturek S.J., Brzozowski T., Dembinski A., Zembala M., Mytar B., Hahn E.G. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischaemia-induced lesions is mediated by scavenge of oxygen radicals. Scand. J. Gastroenterol. 32:1997;433-438.
17. Kourounakis A.P., Rekka E.A., Kourounakis P.N. Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity. J. Pharm. Pharmacol. 49:1997;938-942.
18. Kourounakis P.N., Rekka E.A. Interactions of ethanol with drugs: effect on drug activity, metabolism and hepatic functions. A comparative study with known microsomal enzyme inducers. Sci. Pharm. 55:1987;49-55.
19. Kourounakis A.P., Galanakis D., Tsiakitzis K., Rekka E.A., Kourounakis P.N. Synthesis and pharmacological evaluation of novel derivatives of anti-inflammatory drugs with increased antioxidant and anti-inflammatory activities. Drug Dev. Res. 47:1999;9-16.
20. McCormack K. The spinal action of non-steroidal anti-inflammatory drugs and dissociation between their anti-inflammatory and analgesic effects. Drugs. 47(Suppl. 5):1994;28-47.
21. Naik S.R., Kalyampur S., Sheth U.K. Effects of anti-inflammatory drugs on glutathione levels and liver succinic dehydrogenase activity in carrageenin edema and cotton pallet granuloma in rats. Biochem. Pharmacol. 21(4):1972;311-316.
22. Rekka E.A., Psarras N., Kourounakis P.N. The involvement of tolfenamic acid, mefenamic acid and nimesulide in free radical processes. Pharm. Sci. 1:1995;483-486.
23. Salim A.S. Role of sulfhydryl-containing agents in the healing of erosive gastritis and chronic gastric ulceration in the rat. J. Pharm. Sci. 81(11):1992;70-73.
24. Schmidt E., Figula V., Roth D., Ullrich V. Antioxidant and neutrophil-inhibiting properties of new 2-O-methyl-6-(alkylthio)ascorbic acid derivatives. J. Med. Chem. 36:1993;4021-4029.
25. Shanbhag V.R., Crider A.M., Gokhale R., Harpalani A., Dick R.M. Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity and gastrointestinal toxicity. J. Pharm. Sci. 81:1992;149-154.
26. Son M., Kim H.K., Kim W.B., Yang J., Kim B.K. Protective effect of taurine on indomethacin-induced gastric mucosal injury. Adv. Exp. Med. Biol. 403:1996;147-155.
27. Szabo S., Trier J.S., Frankel P.N. Sulfhydryl compounds may mediate gastric cytoprotection. Science. 214(4317):1981;200-202.
28. Tanaka J., Yuda Y. Lipid peroxidation in gastric mucosal lesions induced by indomethacin in rats. Biol. Pharm. Bull. 19(3):1996;716-720.
29. Tenenbaum J. The epidemiology of non-steroidal anti-inflammatory drugs. Can. J. Gastroenterol. 13:1999;119-122.
30. Wallace J.L. Selective COX-2 inhibitors: is the water becoming muddy? Trends Pharmacol. Sci. 20:1999;4-6.
31. Wallace J.L., Cirino G. The development of gastrointestinal-sparing non-steroidal anti-inflammatory drugs. Trends Pharmacol. Sci. 15:1994;405-406.